| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 11/25/2010 | US20100297097 Compounds |
| 11/25/2010 | US20100297094 Therapy or prevention of diseases with cells or cell supernatant |
| 11/25/2010 | US20100297066 Biodegradable peptide releasing polymers |
| 11/25/2010 | US20100297054 1,2,3-triazole derivatives for use as stearoyl-coa desaturase inhibitors |
| 11/25/2010 | US20100297046 Compositions and Methods Related to Fructosamine-3-Kinase Inhibitors |
| 11/25/2010 | US20100297031 Orodispersible tablets |
| 11/25/2010 | US20100297025 Novel compositions magnetic particles covered with gem-bisphosphonate derivatives |
| 11/25/2010 | US20100297021 Variants of C-Type Natriuretic Peptide |
| 11/25/2010 | CA2816448A1 Treatment of heart failure with normal ejection fraction |
| 11/25/2010 | CA2763156A1 Identification of micro-rnas involved in post-myocardial infarction remodeling and heart failure |
| 11/25/2010 | CA2762939A1 Self-emulsifying composition of .omega.3 fatty acid |
| 11/25/2010 | CA2762226A1 Isoquinolin-1 (2h) -one derivatives as parp-1 inhibitors |
| 11/25/2010 | CA2758581A1 Variants of c-type natriuretic peptide |
| 11/24/2010 | EP2253646A1 Anti-dual integrin antibody and compositions and conjugates comprising said antibody |
| 11/24/2010 | EP2253642A1 Polypeptides, cDNAs encoding the same and utilization thereof |
| 11/24/2010 | EP2253633A1 Fused heterocyclic compound |
| 11/24/2010 | EP2253327A1 Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound |
| 11/24/2010 | EP2253318A1 Improvement of dissolvability of preparation containing olmesartan medoxomil |
| 11/24/2010 | EP2252688A1 Synthetic phosphodiester oligonucleotides and therapeutical uses thereof |
| 11/24/2010 | EP2252619A1 Isothiazole-pyridine derivatives as modulators of hif (hypoxia inducible factor) activity |
| 11/24/2010 | EP2252613A1 Compounds and compositions as modulators of gpr119 activity |
| 11/24/2010 | EP2252612A1 Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 11/24/2010 | EP2252610A1 Substituted piperidines as renin inhibitors |
| 11/24/2010 | EP2252589A2 6-and 7-amino isoquinoline compounds and methods for making and using the same |
| 11/24/2010 | EP2252586A1 Compounds and compositions as modulators of gpr119 activity |
| 11/24/2010 | EP2252371A1 Egg products with components recognized for reducing the levels of cholesterol in people and/or improving their health |
| 11/24/2010 | EP2252324A1 Method for increasing the activity of the immune system of a mammal at risk of inflammatory diseases |
| 11/24/2010 | EP2252321A2 Treatment and prevention of cardiac conditions using two or more isoforms of hepatocyte growth factor |
| 11/24/2010 | EP2252318A2 Methods of treating inflammation |
| 11/24/2010 | EP2252309A1 Nutritional compositions for promotion of bone growth and maintenance of bone health comprising extracts of for example rosemary or caraway |
| 11/24/2010 | EP2252300A1 Use of 2,4-pyrimidinediamines for the treatment of atherosclerosis |
| 11/24/2010 | EP2252297A1 Protective effect of high dose folate on mycardial ischemia |
| 11/24/2010 | EP2252295A1 Use of ranolazine for the treatment of cardiovascular diseases |
| 11/24/2010 | EP2252283A1 Synthetic triterpenoids and methods of use in the treatment of disease |
| 11/24/2010 | EP2252273A1 Solid pharmaceutical composition comprising a non-peptide angiotensin ii receptor antagonist and a diuretic |
| 11/24/2010 | EP2091531B1 Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting mpt |
| 11/24/2010 | EP2034999B1 Dha esters and use thereof in the treatment and the prevention of cardiovascular diseases |
| 11/24/2010 | EP1899330B1 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect |
| 11/24/2010 | EP1896430B1 The preparation and use of compounds as aspartyl protease inhibitors |
| 11/24/2010 | EP1549156B1 Denatured carob flour (dcf) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it |
| 11/24/2010 | EP1546375B1 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 11/24/2010 | EP1539739B1 Piperidinyl compounds that selectively bind integrins |
| 11/24/2010 | EP1497287B1 Quinoline derivatives in combination with 5-FU or CPT-11 for use in the treatment of cancer |
| 11/24/2010 | EP1497285B1 Benzoxazinone-derived compounds, their preparation und use as medicaments |
| 11/24/2010 | EP1474387B1 Derivatives of alpha-phenylthiocarboxylic and alpha-phenyloxy-carboxylic acids useful for the treatment of diseases responding to ppar alpha activation |
| 11/24/2010 | EP1429819B1 Optimized dosing for paclitaxel coated stents |
| 11/24/2010 | EP1370260B1 Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 11/24/2010 | CN1960705B Therapeutic foam |
| 11/24/2010 | CN1942181B Tablet containing branched chain amino acid and process for producing the same |
| 11/24/2010 | CN1903268B Medicine composition for treating atherosclerosis and its prepn. method |
| 11/24/2010 | CN1880304B Triamide-substituted indoles, benzofuranes and benzothiophenes |
| 11/24/2010 | CN1861087B High purity wild Radix scutellariae glucoside medicine composition, and application of making medicine to treat diseases of cardiovascular and cerebrovascular |
| 11/24/2010 | CN1578660B Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
| 11/24/2010 | CN101896490A Trisubstituted piperidines as renin inhibitors |
| 11/24/2010 | CN101896470A Dual-acting benzoimidazole derivative and their use as antihypertensive agents |
| 11/24/2010 | CN101896185A Oxazolidinones for the treatment and/or prophylaxis of heart failure |
| 11/24/2010 | CN101896181A Use of ranolazine for elevated brain-type natriuretic peptide |
| 11/24/2010 | CN101892249A Pufa polyketide synthase systems and uses thereof |
| 11/24/2010 | CN101891834A Polysaccharide sulfate fragment (PSC), preparation method and application thereof |
| 11/24/2010 | CN101891817A Monoclonal antibody capable of preventing high mobility group box-1 (HMGB-1) and application thereof |
| 11/24/2010 | CN101891747A Compound capable of inhibiting phosphodiesterase type 5 and preparation method |
| 11/24/2010 | CN101891735A Biphenyl sulfafurazole compound, synthesis method and application thereof |
| 11/24/2010 | CN101891728A Scutellarein derivative as well as preparation method and application thereof |
| 11/24/2010 | CN101891715A Novel compound and preparation method and use thereof |
| 11/24/2010 | CN101891596A New compound and preparation method and application thereof |
| 11/24/2010 | CN101890167A Conveniently implantable sustained release drug compositions |
| 11/24/2010 | CN101890166A Combination of organic compounds |
| 11/24/2010 | CN101890165A Composition for lowering blood pressure and application thereof |
| 11/24/2010 | CN101890151A Application of corn oligopeptide preparation in preparation of medicaments for reducing blood pressure and healthcare foods |
| 11/24/2010 | CN101890133A Medicine for lowering high blood pressure |
| 11/24/2010 | CN101890119A Medicament for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
| 11/24/2010 | CN101890109A Medicament for treating cardiovascular and cerebrovascular diseases |
| 11/24/2010 | CN101890061A Method for preparing ginkgo biloba leaf extract injection, and ginkgo biloba leaf extract injection |
| 11/24/2010 | CN101890058A Health-care bio-chip based on nano-taxus and preparation method thereof |
| 11/24/2010 | CN101890057A Chinese brake herb preparation for treating gastrointestinal tract and urinary tract infections and cardiovascular and cerebrovascular diseases and preparation method thereof |
| 11/24/2010 | CN101890046A Composition with heart rate reducing properties |
| 11/24/2010 | CN101890024A Candesartan cilexetil/hydrochlorothiazide composition and preparation method thereof |
| 11/24/2010 | CN101889998A Composition and application thereof as TR3 receptor inducer |
| 11/24/2010 | CN101889986A Flunarizine orally disintegrating tablet and preparation method thereof |
| 11/24/2010 | CN101889985A Medicament-carrying nano microspheres and preparation method thereof |
| 11/24/2010 | CN101889978A Pharmaceutical composition containing vinpocetine, preparation method and application thereof |
| 11/24/2010 | CN101889977A Pyritinol hydrochloride injection and preparation method thereof |
| 11/24/2010 | CN101889975A Rosuvastatin calcium sustained-release preparation and preparation method thereof |
| 11/24/2010 | CN101889953A Device and method for manufacturing drug smoke liquid and drug smoke |
| 11/24/2010 | CN101889687A Selenium-enriched white red-rooted salvia root tea and preparation method thereof |
| 11/24/2010 | CN101229140B Nifedipine sustained release preparation and preparing method thereof |
| 11/24/2010 | CN101229132B Nimodipine pulse sustained release mircopill preparation and preparing method thereof |
| 11/24/2010 | CN101199504B Function of stilbene oxygen acid or salt in preparing antiatheroscloresis medicament |
| 11/24/2010 | CN101181327B Chinese medicine compound preparations for preventing and curing cataptosis and chest bi-syndrome as well as preparation method thereof |
| 11/24/2010 | CN101139393B KDR peptides and vaccines containing the same |
| 11/24/2010 | CN101137361B Potassium channel opener having benzofuroindole skeleton |
| 11/24/2010 | CN101057905B Microwave extraction method for cordate houttuynia total flavones |
| 11/24/2010 | CN101049297B High DNA type fatty ethyl ester in high purity, manufacturing method and preparation |
| 11/24/2010 | CN101045715B Heterocycle inhibitor for glycogen synthase kinase gsk-3 |
| 11/23/2010 | US7838644 oversulfation of epiK-N sulfate to obtain an epiK5-amine-O-oversulfate with very high sulfation degree which by subsequent N-sulfation provides new epiK5-N,O-oversulfate-derivatives; free of activity on the coagulation parameters and useful in the cosmetic or pharmaceutical field |
| 11/23/2010 | US7838562 treating a mammal for a vascular permeability disorder by administering a vascular endothelial sphingosine-1-phosphate receptor agonist comprising 2-amino-2-[2-(4-octaphenyl)ethyl]propane-1,3 diol, or 2-amino-2-methyl-4-[4-heptoxy-phenyl]butane-1-ol |
| 11/23/2010 | US7838558 adapalene in topical gels, creams or lotions in higher concentration for skin disorders such as acne |
| 11/23/2010 | US7838555 Useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and |
| 11/23/2010 | US7838541 Methods of using aryl ureas to treat diseases mediated by the VEGF induced signal transduction pathway characterized by abnormal angiogenesis or hyperpermeability processes. |
| 11/23/2010 | US7838510 Biomaterials based on hyaluronic acid for the anti-angiogenic therapy in the treatment of tumors |